Kuraray Co. (OTCMKTS:KURRY – Get Free Report) saw a large growth in short interest during the month of October. As of October 30th, there was short interest totaling 7 shares, a growth of 600.0% from the October 15th total of 1 shares. Based on an average daily volume of 46 shares, the short-interest ratio is presently 0.2 days. Currently, 0.0% of the company’s shares are sold short.
Kuraray Price Performance
KURRY stock remained flat at $36.93 during midday trading on Thursday. 112 shares of the company’s stock traded hands, compared to its average volume of 54. The company has a market cap of $3.72 billion, a price-to-earnings ratio of 69.68 and a beta of 0.05. The company has a current ratio of 2.63, a quick ratio of 1.45 and a debt-to-equity ratio of 0.30. Kuraray has a 12-month low of $27.64 and a 12-month high of $38.00. The business has a 50-day moving average price of $33.43 and a 200-day moving average price of $32.79.
Kuraray (OTCMKTS:KURRY – Get Free Report) last released its earnings results on Wednesday, November 11th. The company reported $1.70 earnings per share for the quarter. Kuraray had a return on equity of 5.37% and a net margin of 0.92%. The firm had revenue of $1.33 billion for the quarter.
Kuraray Company Profile
Kuraray Co., Ltd. is a Japanese specialty chemicals and materials company that develops and manufactures products for industrial and consumer applications. Its portfolio includes polyvinyl alcohol (PVA) resin and fiber, ethylene vinyl alcohol (EVOH) resin, synthetic leather, activated carbon, and specialty chemicals. The company’s materials are used in applications such as packaging, automotive components, construction, electronics, water treatment, and healthcare. Kuraray also produces functional resins, elastomers, fibers, and other performance materials, including products sold under brands such as EVAL, KURALON, and CLARINO.
Featured Stories
- Five stocks we like better than Kuraray
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
- Midterm Fallout, NVIDIA Turmoil, Anthropic’s IPO: Is Broadcom a Steal?
- 3 Pharmaceutical Stocks That Offer Safety and Growth
Receive News & Ratings for Kuraray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kuraray and related companies with MarketBeat.com's FREE daily email newsletter.
